GB:AOTI Stock Latest News
Company AnnouncementsAOTI, Inc. Earnings Call Highlights Growth And CMS Pivot1M agoAOTI
Company AnnouncementsAOTI builds momentum ahead of transformative Medicare decision as H1 revenue and EBITDA climb1M ago
Company AnnouncementsAOTI Gains Unanimous Support in CMS Meeting on Medicare Coverage for Topical Oxygen Therapy2M ago
Company AnnouncementsAOTI Executives Boost Holdings Through Employee Share Purchase Plan3M ago
Company AnnouncementsAOTI Set for Major U.S. Market Expansion as CMS Backs Coverage for TWO2 Therapy3M agoCompany AnnouncementsAOTI Director Increases Stake as Wound-Care Specialist Expands Global Reach5M ago
Company AnnouncementsAOTI Shareholders Back All AGM Resolutions, Expanding Capital Flexibility5M ago
Company AnnouncementsAOTI launches employee share plan to align staff with growth strategy6M ago
Company AnnouncementsAOTI’s At-Home Oxygen Therapy Delivers Strong Real-World Wound Healing Results6M ago
Company AnnouncementsAOTI Ties New Executive Share Awards to Multi‑Year Profitability Targets6M ago
Company AnnouncementsAOTI Publishes 2025 Annual Report and Sets May 2026 AGM in London7M ago
Company AnnouncementsAOTI Chairman Restructures Shareholding With No Change in Overall Stake7M agoCompany AnnouncementsAOTI Delivers Double-Digit 2025 Revenue Growth Amid U.S. Healthcare Disruption7M ago
Company AnnouncementsAOTI posts solid 2025 growth but halts new Arizona Medicaid patients amid reimbursement dispute8M ago
- Company AnnouncementsAOTI’s Innovative Approach to Treating Venous Leg Ulcers: A Clinical Study Update1y agoAOTI
- Company AnnouncementsAOTI, Inc. Strengthens Brokerage Team with New Appointment1y ago
- Company AnnouncementsAOTI, Inc. Reports Strong H1 2025 Revenue Growth Amidst US Healthcare Challenges1y ago
- Company AnnouncementsAOTI, Inc. to Release Interim Results and Host Investor Meetings1y ago
Company AnnouncementsAOTI’s TWO2® Therapy Gains NICE Recommendation and NHS Framework Inclusion1y ago



